A drug with the SMILES Cc1nn(CCC#N)c(NC(=O)c2ccc(Cl)cc2Cl)c1P(=O)(Nc1ccc([N+](=O)[O-])cc1)N1CCOCC1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -12.634%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1nn(CCC#N)c(NC(=O)c2ccc(Cl)cc2Cl)c1P(=O)(Nc1ccc([N+](=O)[O-])cc1)N1CCOCC1
Cc1nn(CCC#N)c(NC(=O)c2ccc(Cl)cc2Cl)c1P(=O)(Nc1ccc([N+](=O)[O-])cc1)N1CCOCC1
2,4-dichloro-N-[2-(2-cyanoethyl)-5-methyl-4-[morpholin-4-yl-(4-nitroanilino)phosphoryl]pyrazol-3-yl]benzamide